TriLink Biotechnologies said today that it has entered into a distribution agreement with Australia's Astral Scientific.
Terms of the agreement call for Astral to sell San Diego-based TrLink's modified nucleic acid products, including more than 150 modified nucleotides, custom oligonucleotides, and CleanAmp Hot Start PCR products.
Astral, based in the Sydney area, supplies the clinical diagnostics, life science research, and industrial markets.